August 24, 2001

Mail Stop 0304

United States Securities and Exchange Commission
Washington, D.C. 20549

Re:      Molecular Diagnostics and Therapeutics, Inc.
         RW- Registration Statement on Form SB-2
         File No. 333-33662
         Filed: 8-24-01

Dear Commissioners:

         Please  accept this as the above  registrant's  request to withdraw the
above Registration Statement.  The withdrawal was requested because the offering
period has  expired  and no sales have been made  pursuant  to the  Registration
Statement (Rules 477).

         The Company may undertake  subsequent  private offerings in reliance on
Securities Act Rule 155(C).

                                               Sincerely,

                                               /s/ Malcolm H. Benedict
                                               ------------------------------
                                               Malcolm H. Benedict
                                               President and C.E.O.